The Endovascular Treatment Devices Market is expected to be around US$ 4.50 Billion by 2028 at a CAGR of 7.6% in the given forecast period.
The rising geriatric population globally is going to drive the market. Acquiring various diseases by elderly people are at high risk.
Rising consent of endovascular procedures and increasing diagnosis of aortic aneurysms globally are the factors that help to drive the Endovascular Treatment Devices Market.
The global Endovascular Treatment Devices market is segregated on the basis of Application as Clinic, Hospital, and Other. Based on Product the global Endovascular Treatment Devices market is segmented in Thoracic Endovascular Aortic/aneurysm Repair (TEVAR) and Endovascular Aortic Repair (EVAR).
The global Endovascular Treatment Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Endovascular Treatment Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Japan Lifeline Co. Ltd., Kawasumi Laboratories, Microport Scientific, Medtronic, Nellix Inc. (Subsidiary of Endologix), Terumo Corp., Braile Biomedica, Cardiatis Sa, Altura Medical (Subsidiary Of Lombard Medical), Biflow Medical, and others are among the major players in the global Endovascular Treatment Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Endovascular Treatment Devices Market has been segmented as below:
Endovascular Treatment Devices Market, By Application
Endovascular Treatment Devices Market, By Product
Endovascular Treatment Devices Market, By Region
Endovascular Treatment Devices Market, By Company
The report covers:
Report Scope:
The global Endovascular Treatment Devices market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Endovascular Treatment Devices market share. Major industry players with significant revenue share include Japan Lifeline Co. Ltd., Kawasumi Laboratories, Microport Scientific, Medtronic, Nellix Inc. (Subsidiary of Endologix), Terumo Corp., Braile Biomedica, Cardiatis Sa, Altura Medical (Subsidiary of Lombard Medical), Biflow Medical, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Overactive Bladder Treatment Market
Ocular Inflammation Treatment Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Endovascular Treatment Devices Market, By Application
5.1 Introduction
5.2 Clinic
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Hospital
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Endovascular Treatment Devices Market, By Product
6.1 Introduction
6.2 Thoracic Endovascular Aortic/aneurysm Repair (TEVAR)
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Endovascular Aortic Repair (EVAR)
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Endovascular Treatment Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Endovascular Treatment Devices, By Application
7.2.2 North America Endovascular Treatment Devices, By Product
7.3 Europe
7.3.1 Europe Endovascular Treatment Devices, By Application
7.3.2 Europe Endovascular Treatment Devices, By Product
7.4 Asia-Pacific
7.4.1 Asia-Pacific Endovascular Treatment Devices, By Application
7.4.2 Asia-Pacific Endovascular Treatment Devices, By Product
7.5 Rest of the World
7.5.1 Rest of the World Endovascular Treatment Devices, By Application
7.5.2 Rest of the World Endovascular Treatment Devices, By Product
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Japan Lifeline Co. Ltd.
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Kawasumi Laboratories
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Microport Scientific
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Medtronic
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Nellix Inc. (Subsidiary Of Endologix)
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Terumo Corp.
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Braile Biomedica
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Cardiatis Sa
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Altura Medical (Subsidiary Of Lombard Medical)
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Biflow Medical
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Endovascular Treatment Devices Market has been segmented as below:
Endovascular Treatment Devices Market, By Application
Endovascular Treatment Devices Market, By Product
Endovascular Treatment Devices Market, By Region
Endovascular Treatment Devices Market, By Company
